Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Cordfunke

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Biomolecules|April 23, 2022
Membrane Activity of LL-37 Derived Antimicrobial Peptides against <i>Enterococcus hirae</i>: Superiority of SAAP-148 over OP-145Paulina Piller, Heimo Wolinski, Robert A Cordfunke, et al.
Biomolecules|September 23, 2022
Where Electrostatics Matter: Bacterial Surface Neutralization and Membrane Disruption by Antimicrobial Peptides SAAP-148 and OP-145Djenana Vejzovic, Paulina Piller, Robert A Cordfunke, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Bactericidal Activity to <i>Escherichia coli</i>: Different Modes of Action of Two 24-Mer Peptides SAAP-148 and OP-145, Both Derived from Human Cathelicidine LL-37Ayse Ön, Djenana Vejzovic, James Jennings, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2025
Protease Specificity Profiling Using Synthetic Combinatorial Peptide Libraries and Mass SpectrometryBart Claushuis, Robert A Cordfunke, Arnoud H de Ru, et al.
Iscience|January 26, 2026
Structural analyses and substrate profiling of PPEP-3 provide new insights into the molecular basis of Pro-Pro endopeptidase specificityBart Claushuis, Fabian Wojtalla, Lisa Papenhagen, et al.
Biochimica Et Biophysica Acta|July 27, 2015
Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systemsNermina Malanovic, Regina Leber, Maria Schmuck, et al.
Vaccine|February 11, 2014
Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancerMarieke F Fransen, Robert A Cordfunke, Marjolein Sluijter, et al.
Annals of Clinical Microbiology and Antimicrobials|December 5, 2019
Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection modelGabrielle S Dijksteel, Magda M W Ulrich, Marcel Vlig, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Novel Antibacterial Agents SAAP-148 and Halicin Combat Gram-Negative Bacteria Colonizing CathetersNesrine Bouhrour, Tanny J K van der Reijden, Michella M Voet, et al.
Frontiers in Pharmacology|December 18, 2025
Branched tetrameric lactoferricin peptides modified with diaminopropionic acid exhibit potent antimicrobial and wound-healing activitiesNikitha Vavilthota, Gizem Babuççu, Robert A Cordfunke, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Biomolecules|April 23, 2022
Membrane Activity of LL-37 Derived Antimicrobial Peptides against <i>Enterococcus hirae</i>: Superiority of SAAP-148 over OP-145Paulina Piller, Heimo Wolinski, Robert A Cordfunke, et al.
Biomolecules|September 23, 2022
Where Electrostatics Matter: Bacterial Surface Neutralization and Membrane Disruption by Antimicrobial Peptides SAAP-148 and OP-145Djenana Vejzovic, Paulina Piller, Robert A Cordfunke, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Bactericidal Activity to <i>Escherichia coli</i>: Different Modes of Action of Two 24-Mer Peptides SAAP-148 and OP-145, Both Derived from Human Cathelicidine LL-37Ayse Ön, Djenana Vejzovic, James Jennings, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2025
Protease Specificity Profiling Using Synthetic Combinatorial Peptide Libraries and Mass SpectrometryBart Claushuis, Robert A Cordfunke, Arnoud H de Ru, et al.
Iscience|January 26, 2026
Structural analyses and substrate profiling of PPEP-3 provide new insights into the molecular basis of Pro-Pro endopeptidase specificityBart Claushuis, Fabian Wojtalla, Lisa Papenhagen, et al.
Biochimica Et Biophysica Acta|July 27, 2015
Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systemsNermina Malanovic, Regina Leber, Maria Schmuck, et al.
Vaccine|February 11, 2014
Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancerMarieke F Fransen, Robert A Cordfunke, Marjolein Sluijter, et al.
Annals of Clinical Microbiology and Antimicrobials|December 5, 2019
Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection modelGabrielle S Dijksteel, Magda M W Ulrich, Marcel Vlig, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Novel Antibacterial Agents SAAP-148 and Halicin Combat Gram-Negative Bacteria Colonizing CathetersNesrine Bouhrour, Tanny J K van der Reijden, Michella M Voet, et al.
Frontiers in Pharmacology|December 18, 2025
Branched tetrameric lactoferricin peptides modified with diaminopropionic acid exhibit potent antimicrobial and wound-healing activitiesNikitha Vavilthota, Gizem Babuççu, Robert A Cordfunke, et al.
Pageof 4